韦德国际1946

公司产品2023年批签发情况

发布时间：

2023-01-29

作者：

来源：

摘要

The company's product 2023 annual batch issuance situation is as follows:

公司产品2023年批签发情况如下表：

The company's product 2023 annual batch issuance situation is as follows:

序号

Serial No.

产品名称

Product Name

批次

Batch

1

无细胞百白破b型流感嗜血杆菌联合疫苗

Diphtheria, Tetanus, Acellular Pertussis and Haemophilus influenzae type b combined vaccine

23批

23 batch

2

23价肺炎球菌多糖疫苗

23-valent pneumococcal polysaccharide vaccine

12批

12 batch

3

 13价肺炎球菌多糖结合疫苗（破伤风类毒素/白喉类毒素）

13- valent pneumococcal polysaccharide conjugate vaccine(TT/DT)

15批

15 batch

4

吸附无细胞百白破联合疫苗

Diphtheria, Tetanus and Acellular Pertussis combined vaccine，Adsorbed

11批

11 batch

 5

冻干b型流感嗜血杆菌结合疫苗

Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried

4 批4 batch

6

冻干人用狂犬病疫苗（人二倍体细胞）

Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried

1 批1 batch

批签发公示：http://bio.nifdc.org.cn/pqf/search.do?formAction=pqfGs

Batch release announcement:http://bio.nifdc.org.cn/pqf/search.do?formAction=pqfGs